Fetomaternal alloimmune thrombocytopenia: The questions that still remain

Janyne Althaus, Karin J. Blakemore

Research output: Contribution to journalReview articlepeer-review

Abstract

Fetomaternal alloimmune thrombocytopenia (FMAIT) occurs when maternal antibodies are formed to fetal platelet antigens, leading to thrombocytopenia and hemorrhagic complications. The diagnosis is frequently made only after a major hemorrhagic event has occurred during a pregnancy. Identifying patients at risk remains difficult, and the optimal treatment regimen remains to be determined.

Original languageEnglish (US)
Pages (from-to)633-637
Number of pages5
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume20
Issue number9
DOIs
StatePublished - Aug 21 2007

Keywords

  • Fetal-maternal thrombocytopenia
  • Intracranial hemorrhage
  • Neonatal alloimmune thrombocytopenia
  • Platelet alloantigens

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Fetomaternal alloimmune thrombocytopenia: The questions that still remain'. Together they form a unique fingerprint.

Cite this